Suzhou
China
7
2021-10-14
6
2022-05-31
These are the the leading inventors for applications assigned to Teligene Ltd.:
Teligene Ltd. based in Suzhou, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Substituted pyrazolopyrimidines useful as kinases inhibitors
#2 | 2021-03-25 ✅ Patent 11,427,559 granted on 2022-08-30Substituted quinolines useful as kinase inhibitors
#3 | 2020-09-17 ✅ Patent 11,034,656 granted on 2021-06-15Maleate salts of (E)-N-(3-cyano-7-ethoxy-4-((4-phenoxyphenyl)amino) quinolin-6-yl)-4-(dimethylamino)but-2-enamide and crystalline forms thereof
#4 | 2018-05-17HETEROCYLCIC COMPOUNDS AS IDH2 INHIBITORS
#5 | 2017-08-03 ✅ Patent 10,159,663 granted on 2018-12-25Substituted macrocycles useful as kinases inhibitors and methods of use thereof
#6 | 2015-12-10 ✅ Patent 10,173,995 granted on 2019-01-08Pyridine compounds used as PI3 kinase inhibitors
#7 | 2014-08-21 ✅ Patent 9,388,160 granted on 2016-07-12Quinazoline derivatives as kinases inhibitors and methods of use thereof
Also check out TELIGENE LTD's (Suzhou, China) applicant profile with 5 patent applications submitted.
75595 ⎘